An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?

Documenti analoghi

• Pathological overproduction: the bad side of adenosine
  di: Borea, Pier Andrea, et al.
  Pubblicazione: (2017)
• A_2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer’s Disease by Regulating NLRP3 Inflammasome Activity?
  di: Stefania Merighi, et al.
  Pubblicazione: (2022-05-01)
• A(1) Adenosine Receptor Partial Agonists and Allosteric Modulators: Advancing Toward the Clinic?
  di: Vincenzi, Fabrizio, et al.
  Pubblicazione: (2020)
• The Detrimental Action of Adenosine on Glutamate-Induced Cytotoxicity in PC12 Cells Can Be Shifted towards a Neuroprotective Role through A(1)AR Positive Allosteric Modulation
  di: Vincenzi, Fabrizio, et al.
  Pubblicazione: (2020)
• Inhibition of A(2A) Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455
  di: Gessi, Stefania, et al.
  Pubblicazione: (2017)